Alnylam Pharmaceuticals
ALNY
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on…
Financial Tools
Revenue Counter
Earns $117.77 every second. See per minute, hour, and day.
Earnings Counter
Earns $9.95 per second net profit. See per minute, hour, and day.
Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
What If Invested
What if you had invested $1,000? See historical returns from any date.
How it makes money
Discover visual breakdown of $3.71B in revenue — where it comes from and where it goes.
Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
Price target scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
Daily Price Character
Explosive · 50.6% historical win rate (green days). Streaks & record days.
Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.